{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0090303",
      "entity_text" : "injury",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q9Y4C1",
      "entity_text" : "KDM3A",
      "features" : [ {
        "modification_type" : "unknown",
        "feature_type" : "modification"
      } ],
      "entity_type" : "gene_or_gene_product"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Our previous study demonstrated that KDM3A expression was upregulated in type 2 diabetic vascular and heart tissue, whereas downregulation of KDM3A markedly promoted rehabilitation of diabetic vascular complications and attenuated diabetic myocardial injury; KDM3A inhibition also significantly alleviated high glucose induced VSMC dysfunction in vitro.",
  "reading_complete" : "2020-08-03T17:02:15Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-03T17:00:55Z",
  "trigger" : "upregulated",
  "evidence" : [ "KDM3A expression was upregulated in type 2 diabetic vascular and heart tissue, whereas downregulation of KDM3A markedly promoted rehabilitation of diabetic vascular complications and attenuated diabetic myocardial injury" ],
  "pmc_id" : "5819917",
  "score" : 0
}